Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 215


Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network.

Chen R, Ryan P, Natarajan K, Falconer T, Crew KD, Reich CG, Vashisht R, Randhawa G, Shah NH, Hripcsak G.

JCO Clin Cancer Inform. 2020 Mar;4:171-183. doi: 10.1200/CCI.19.00107.


Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension.

Hripcsak G, Suchard MA, Shea S, Chen R, You SC, Pratt N, Madigan D, Krumholz HM, Ryan PB, Schuemie MJ.

JAMA Intern Med. 2020 Feb 17. doi: 10.1001/jamainternmed.2019.7454. [Epub ahead of print]


Adapting electronic health records-derived phenotypes to claims data: Lessons learned in using limited clinical data for phenotyping.

Ostropolets A, Reich C, Ryan P, Shang N, Hripcsak G, Weng C.

J Biomed Inform. 2020 Feb;102:103363. doi: 10.1016/j.jbi.2019.103363. Epub 2019 Dec 19.


Neurological Dashboards and Consultation Turnaround Time at an Academic Medical Center.

Kummer BR, Willey JZ, Zelenetz MJ, Hu Y, Sengupta S, Elkind MSV, Hripcsak G.

Appl Clin Inform. 2019 Oct;10(5):849-858. doi: 10.1055/s-0039-1698465. Epub 2019 Nov 6.


Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.

Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB.

Lancet. 2019 Nov 16;394(10211):1816-1826. doi: 10.1016/S0140-6736(19)32317-7. Epub 2019 Oct 24.


Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts.

You SC, Jung S, Swerdel JN, Ryan PB, Schuemie MJ, Suchard MA, Lee S, Cho J, Hripcsak G, Park RW, Park S.

Korean Circ J. 2020 Jan;50(1):52-68. doi: 10.4070/kcj.2019.0173. Epub 2019 Aug 28.


Making work visible for electronic phenotype implementation: Lessons learned from the eMERGE network.

Shang N, Liu C, Rasmussen LV, Ta CN, Caroll RJ, Benoit B, Lingren T, Dikilitas O, Mentch FD, Carrell DS, Wei WQ, Luo Y, Gainer VS, Kullo IJ, Pacheco JA, Hakonarson H, Walunas TL, Denny JC, Wiley K, Murphy SN, Hripcsak G, Weng C.

J Biomed Inform. 2019 Nov;99:103293. doi: 10.1016/j.jbi.2019.103293. Epub 2019 Sep 19.


The parameter Houlihan: A solution to high-throughput identifiability indeterminacy for brutally ill-posed problems.

Albers DJ, Levine ME, Mamykina L, Hripcsak G.

Math Biosci. 2019 Oct;316:108242. doi: 10.1016/j.mbs.2019.108242. Epub 2019 Aug 24.


Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.

eMERGE Consortium. Electronic address:; eMERGE Consortium.

Am J Hum Genet. 2019 Sep 5;105(3):588-605. doi: 10.1016/j.ajhg.2019.07.018. Epub 2019 Aug 22.


Network Analysis of Citation in Hypertension Clinical Guidelines.

Park Y, Kim HW, You SC, Hripcsak G, Cho HE, Han JH, Shin SJ, Park RW.

Stud Health Technol Inform. 2019 Aug 21;264:1017-1020. doi: 10.3233/SHTI190378.


A plea to stop using the case-control design in retrospective database studies.

Schuemie MJ, Ryan PB, Man KKC, Wong ICK, Suchard MA, Hripcsak G.

Stat Med. 2019 Sep 30;38(22):4199-4208. doi: 10.1002/sim.8215. Epub 2019 Aug 22.


The "All of Us" Research Program.

All of Us Research Program Investigators, Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, Jenkins G, Dishman E.

N Engl J Med. 2019 Aug 15;381(7):668-676. doi: 10.1056/NEJMsr1809937.


PheValuator: Development and evaluation of a phenotype algorithm evaluator.

Swerdel JN, Hripcsak G, Ryan PB.

J Biomed Inform. 2019 Sep;97:103258. doi: 10.1016/j.jbi.2019.103258. Epub 2019 Jul 29.


Challenges with quality of race and ethnicity data in observational databases.

Polubriaginof FCG, Ryan P, Salmasian H, Shapiro AW, Perotte A, Safford MM, Hripcsak G, Smith S, Tatonetti NP, Vawdrey DK.

J Am Med Inform Assoc. 2019 Aug 1;26(8-9):730-736. doi: 10.1093/jamia/ocz113.


Facilitating phenotype transfer using a common data model.

Hripcsak G, Shang N, Peissig PL, Rasmussen LV, Liu C, Benoit B, Carroll RJ, Carrell DS, Denny JC, Dikilitas O, Gainer VS, Howell KM, Klann JG, Kullo IJ, Lingren T, Mentch FD, Murphy SN, Natarajan K, Pacheco JA, Wei WQ, Wiley K, Weng C.

J Biomed Inform. 2019 Aug;96:103253. doi: 10.1016/j.jbi.2019.103253. Epub 2019 Jul 17.


Comorbidity Characterization Among eMERGE Institutions: A Pilot Evaluation with the Johns Hopkins Adjusted Clinical GroupsĀ® System.

Taylor CO, Lemke KW, Richards TM, Roe KD, He T, Arruda-Olson A, Carrell D, Denny JC, Hripcsak G, Kiryluk K, Kullo I, Larson EB, Peissig P, Walton NA, Wei-Qi W, Ye Z, Chute CG, Weiner JP.

AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:145-152. eCollection 2019.


Comment on "How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias".

Schuemie MJ, Madigan D, Ryan PB, Reich C, Suchard MA, Berlin JA, Hripcsak G.

Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):1032-1033. doi: 10.1002/pds.4798. Epub 2019 May 8. No abstract available.


Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.

Hellwege JN, Stallings S, Torstenson ES, Carroll R, Borthwick KM, Brilliant MH, Crosslin D, Gordon A, Hripcsak G, Jarvik GP, Linneman JG, Devi P, Peissig PL, Sleiman PAM, Hakonarson H, Ritchie MD, Verma SS, Shang N, Denny JC, Roden DM, Velez Edwards DR, Edwards TL.

Sci Rep. 2019 Apr 15;9(1):6077. doi: 10.1038/s41598-019-42427-z.


Low Screening Rates for Diabetes Mellitus Among Family Members of Affected Relatives.

Polubriaginof FCG, Shang N, Hripcsak G, Tatonetti NP, Vawdrey DK.

AMIA Annu Symp Proc. 2018 Dec 5;2018:1471-1477. eCollection 2018.


Temporal biomedical data analytics.

Moskovitch R, Shahar Y, Wang F, Hripcsak G.

J Biomed Inform. 2019 Feb;90:103092. doi: 10.1016/j.jbi.2018.12.006. Epub 2019 Jan 14. No abstract available.

Supplemental Content

Loading ...
Support Center